Clinical Trial Update: Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients [NA]

View source ↗

Summary

Completed clinical trial evaluating renal protective effects of a Renin-Angiotensin System (RAS) inhibitor in peritoneal dialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Renin-angiotensin system inhibitor

Snippet

Sponsor: Sun Yat-sen University | Conditions: Renal Function Disorder | NA | Status: COMPLETED